The Finnish Research Impact Foundation awarded Professor Riitta Lahesmaa €224,639 in funding for a project that explores a treatment of cancer which utilizes body’s own immune defense system. Lahesmaa is the Director of the Turku Bioscience Center and InFLAMES flagship group leader. The research is conducted in cooperation with Orion Pharma.

Read the full article in Finnish